No Data
No Data
Vincerx Pharma Announces Cost-Cutting Measures and Exploration of Strategic Alternatives to Advance VIP943 Clinical Development
Express News | Vincerx Pharma Inc: To Streamline Operations and Focus Resources, Vincerx Will Implement a Significant Reduction in Force of Approximately 55%
Express News | Vincerx Pharma Inc: Will Begin Exploring Strategic Alternatives to Complement Ongoing Fundraising Efforts
Express News | Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943
Vincerx Pharma | 10-Q: Q3 2024 Earnings Report
Unlock the Full List